Asarina Pharma Company
Asarina Pharma is a Swedish biotech company developing Sepranolone for Allopregnanolone-related stress, compulsion, menstrual and neurological disorders.
Headquarters:
Solna, Stockholms Lan, Sweden
Total Funding:
$24,828,814
Founded Date:
01-01-2006
Employee Number:
1-10
Last Funding Type:
Post-IPO Equity
Investors Number:
4
Last Funding Date:
2018-09-20
Funding Status:
IPO
Estimated Revenue:
Less than $1M
Industry:
General Health Care